You appear to be offline. Some data may be unavailable until your connection is restored.
ARE
StockAlexandria Real Estate Equities Inc
Price data not available
Description
Alexandria Real Estate Equities, Inc. is a publicly traded real‑estate investment trust that acquires, develops, and leases purpose‑built laboratory, office and collaborative campus spaces for companies in the life‑science, biotech and pharmaceutical sectors. The firm operates primarily in high‑barrier U.S. innovation clusters such as Greater Boston, the San Francisco Bay Area, San Diego, New York City, Seattle and Research Triangle Park, providing tenants with specialized infrastructure, proximity to research institutions and a supportive ecosystem. Alexandria is widely recognized as the leading specialist REIT for life‑science real estate, distinguished by its “Megacampus” campus model that clusters diverse tenants to foster collaboration and by its venture‑capital platform that invests in early‑stage life‑science companies. Its business model relies on long‑term, triple‑net leases with premium rents reflecting the critical, mission‑essential nature of laboratory space. This focus makes Alexandria a unique provider of mission‑critical real‑estate within the broader commercial property market.
Quarterly EarningsQuarterly earnings results, including reported and estimated earnings per share (EPS), for the most recent fiscal quarters.Surprise compares reported EPS with the prior estimate.
| Quarter | DateReport date | EPSReported EPS |
|---|---|---|
| Q4 FY26 | Jan 25, 2027 (est.) | — |
| Q3 FY26 | Oct 26, 2026 | $1.54 |
| Q2 FY26 | Aug 3, 2026 | $1.73 |
| Q1 FY26 | Apr 27, 2026 | $2.10 |
| Q4 FY25 | Jan 26, 2026 | -$6.35 |
Stay ahead of ARE earnings
Get reminders ahead of ARE's next earnings report, so you always know when results are coming.